Culture Change At GSK: 'We’re Doing What We Said We’d Do'

R&D Chief Says Doubters Are Coming Round

Chief scientific offficer Hal Barron talks about winning hearts and minds of 10,000 R&D employees, and adopting practices from acquired company Tesaro.  

GSK_HQ
GSK is adopting 'smart risk taking' in R&D • Source: GSK

GlaxoSmithKline PLC is pressing ahead with a transformation in its culture, with new emphasis on clear decision-making and a focus on "smart risk taking"already making an impact, according to Hal Barron.

The company’s chief scientific officer and president of R&D has been at the UK-headquartered firm for just under two years,...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Immuno-oncology

More from Anticancer